https://staging.immunomarksummit.com/blogs/understanding-pd-l1-as-a-predictive-biomarker-clinical-insights-for-precision-oncology/ 2026-04-06T12:41:14+00:00 https://staging.immunomarksummit.com/wp-content/uploads/2026/04/Understanding-PD-L1-as-a-Predictive-Biomarker_-Clinical-Insights-for-Precision-Oncology.jpg https://staging.immunomarksummit.com/wp-content/uploads/2026/04/chart.jpg https://staging.immunomarksummit.com/wp-content/uploads/2026/04/Stay-Current-in-This-Rapidly-Evolving-Field-With-The-ImmunoMark-Summit.jpg https://staging.immunomarksummit.com/wp-content/uploads/2026/04/scientific-highlights.jpg https://staging.immunomarksummit.com/blogs/fda-companion-diagnostic-approval-process-a-step-by-step-regulatory-guide/ 2026-04-06T12:41:14+00:00 https://staging.immunomarksummit.com/wp-content/uploads/2026/04/The-FDA-Companion-Diagnostic-Approval-Process_-A-Regulatory-Guide-for-Clinical-Development-and-RA-Teams.jpg https://staging.immunomarksummit.com/blogs/speaker-spotlight-series-pioneers-shaping-io-biomarker-science/ 2026-04-06T12:41:14+00:00 https://staging.immunomarksummit.com/wp-content/uploads/2026/04/Speaker-Spotlight-Series_-Pioneers-Shaping-IO-Biomarker-Science.jpg https://staging.immunomarksummit.com/blogs/tumor-mutational-burden-tmb-from-research-to-clinical-reality/ 2026-04-06T12:41:14+00:00 https://staging.immunomarksummit.com/wp-content/uploads/2026/04/Tumor-Mutational-Burden-TMB_-From-Research-to-Clinical-Reality.jpg https://staging.immunomarksummit.com/blogs/boston-biotech-life-sciences-events-2026-complete-guide/ 2026-04-06T12:41:14+00:00 https://staging.immunomarksummit.com/wp-content/uploads/2026/04/Boston-Biotech-Life-Sciences-Events-2026_-Complete-Guide.jpg https://staging.immunomarksummit.com/blogs/best-immuno-oncology-conferences-to-attend-in-2026/ 2026-04-06T12:42:20+00:00 https://staging.immunomarksummit.com/wp-content/uploads/2026/04/Best-Immuno-Oncology-Conferences-to-Attend-in-2026.jpg https://staging.immunomarksummit.com/blogs/how-to-validate-an-io-biomarker-in-a-clinical-trial-expert-guidance/ 2026-05-13T10:31:00+00:00 https://staging.immunomarksummit.com/wp-content/uploads/2026/05/How-to-Validate-an-IO-Biomarker-in-a-Clinical-Trial-Expert-Guidance.webp https://staging.immunomarksummit.com/blogs/car-t-cell-therapy-biomarkers-can-we-finally-predict-who-will-respond/ 2026-05-13T10:45:20+00:00 https://staging.immunomarksummit.com/wp-content/uploads/2026/05/CAR-T-Cell-Therapy-Biomarkers-Can-We-Finally-Predict-Who-Will-Respond.webp https://staging.immunomarksummit.com/blogs/sponsoring-immunomark-summit-boston-an-roi-guide-for-diagnostics-and-pharma-companies/ 2026-05-13T10:53:02+00:00 https://staging.immunomarksummit.com/wp-content/uploads/2026/05/Sponsoring-ImmunoMark-Summit-Boston-An-ROI-Guide-for-Diagnostics-and-Pharma-Companies.webp https://staging.immunomarksummit.com/blogs/multiplex-immunoassay-platform-comparison-guide-2026/ 2026-05-13T10:59:06+00:00 https://staging.immunomarksummit.com/wp-content/uploads/2026/05/Multiplex-Immunoassay-Platform-Comparison-Guide-2026.webp https://staging.immunomarksummit.com/blogs/immunomark-summit-boston-2026-everything-you-need-to-know/ 2026-05-13T11:05:58+00:00 https://staging.immunomarksummit.com/wp-content/uploads/2026/05/ImmunoMark-Summit-Boston-2026-Everything-You-Need-to-Know.webp https://staging.immunomarksummit.com/blogs/ivd-companion-diagnostic-co-development-structuring-pharma-diagnostics-partnerships/ 2026-05-13T11:11:45+00:00 https://staging.immunomarksummit.com/wp-content/uploads/2026/05/IVD-Companion-Diagnostic-Co-Development-Structuring-Pharma-Diagnostics-Partnerships.webp https://staging.immunomarksummit.com/blogs/why-precision-medicine-is-changing-cancer-treatment-in-2026/ 2026-05-13T11:40:40+00:00 https://staging.immunomarksummit.com/wp-content/uploads/2026/05/Why-precision-medicine-is-changing-cancer-treatment-in-2026.webp